Using n-of-1 trials as a clinical tool to improve prescribing

C. Jane Nikles, Alexandra M. Clavarino, Chris B. Del Mar

Research output: Contribution to journalArticleResearchpeer-review

49 Citations (Scopus)

Abstract

Background: N-of-1 trials are within-patient, randomised, double-blind, placebo-controlled cross-over comparisons of two drugs for chronic illnesses. We have investigated the use of these, offered to doctors as individualised medication effectiveness tests (IMETs), as a tool to improve drug prescribing. Aim: To examine patient perspectives and experiences of n-of-1 trials. Design of study: We provided n-of-1 trials for osteoarthritis (OA), comparing paracetamol and ibuprofen; and attention deficit hyperactivity disorder (ADHD), comparing dexamphetamine or methylphenidate and placebo. Patients or their carers were surveyed before and after the trials by questionnaire, and after the trial by semi-structured interview with thematic analysis. Setting: Australian community-based patients and practitioners. Method: Forty-two patients with OA and 21 carers of patients with ADHD, for whom the effectiveness of proposed or existing medication was uncertain, completed the questionnaires, and 25 patients/carers (11 with OA and 14 with ADHD) participated in semi-structured interviews. Results: Patients in this purposive sample were generally very satisfied with the n-of-1 trial process. Their participation led to increased knowledge, awareness and understanding of their condition, their bodies' response to it, and its management. Some of this arose specifically from use of daily symptom diaries. This led to a sense of empowerment and control as well as improved individually-focused care. Conclusions: N-of-1 trials appeared to empower these patients as a result of both collecting information about their responses to different treatment options, and participating actively in subsequent therapeutic decisions. They are a patient-centred intervention that may improve medication management in suitable chronic diseases.

Original languageEnglish
Pages (from-to)175-180
Number of pages6
JournalBritish Journal of General Practice
Volume55
Issue number512
Publication statusPublished - Mar 2005

Fingerprint

Attention Deficit Disorder with Hyperactivity
Osteoarthritis
Caregivers
Chronic Disease
Placebos
Interviews
Drug Prescriptions
Dextroamphetamine
Methylphenidate
Ibuprofen
Acetaminophen
Therapeutics
Pharmaceutical Preparations
Surveys and Questionnaires

Cite this

Nikles, C. Jane ; Clavarino, Alexandra M. ; Del Mar, Chris B. / Using n-of-1 trials as a clinical tool to improve prescribing. In: British Journal of General Practice. 2005 ; Vol. 55, No. 512. pp. 175-180.
@article{1862b3b8d75b4f048a81eaae70f42797,
title = "Using n-of-1 trials as a clinical tool to improve prescribing",
abstract = "Background: N-of-1 trials are within-patient, randomised, double-blind, placebo-controlled cross-over comparisons of two drugs for chronic illnesses. We have investigated the use of these, offered to doctors as individualised medication effectiveness tests (IMETs), as a tool to improve drug prescribing. Aim: To examine patient perspectives and experiences of n-of-1 trials. Design of study: We provided n-of-1 trials for osteoarthritis (OA), comparing paracetamol and ibuprofen; and attention deficit hyperactivity disorder (ADHD), comparing dexamphetamine or methylphenidate and placebo. Patients or their carers were surveyed before and after the trials by questionnaire, and after the trial by semi-structured interview with thematic analysis. Setting: Australian community-based patients and practitioners. Method: Forty-two patients with OA and 21 carers of patients with ADHD, for whom the effectiveness of proposed or existing medication was uncertain, completed the questionnaires, and 25 patients/carers (11 with OA and 14 with ADHD) participated in semi-structured interviews. Results: Patients in this purposive sample were generally very satisfied with the n-of-1 trial process. Their participation led to increased knowledge, awareness and understanding of their condition, their bodies' response to it, and its management. Some of this arose specifically from use of daily symptom diaries. This led to a sense of empowerment and control as well as improved individually-focused care. Conclusions: N-of-1 trials appeared to empower these patients as a result of both collecting information about their responses to different treatment options, and participating actively in subsequent therapeutic decisions. They are a patient-centred intervention that may improve medication management in suitable chronic diseases.",
author = "Nikles, {C. Jane} and Clavarino, {Alexandra M.} and {Del Mar}, {Chris B.}",
year = "2005",
month = "3",
language = "English",
volume = "55",
pages = "175--180",
journal = "Journal of the Royal College of General Practitioners",
issn = "0960-1643",
publisher = "ROYAL COLL GENERAL PRACTITIONERS",
number = "512",

}

Using n-of-1 trials as a clinical tool to improve prescribing. / Nikles, C. Jane; Clavarino, Alexandra M.; Del Mar, Chris B.

In: British Journal of General Practice, Vol. 55, No. 512, 03.2005, p. 175-180.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Using n-of-1 trials as a clinical tool to improve prescribing

AU - Nikles, C. Jane

AU - Clavarino, Alexandra M.

AU - Del Mar, Chris B.

PY - 2005/3

Y1 - 2005/3

N2 - Background: N-of-1 trials are within-patient, randomised, double-blind, placebo-controlled cross-over comparisons of two drugs for chronic illnesses. We have investigated the use of these, offered to doctors as individualised medication effectiveness tests (IMETs), as a tool to improve drug prescribing. Aim: To examine patient perspectives and experiences of n-of-1 trials. Design of study: We provided n-of-1 trials for osteoarthritis (OA), comparing paracetamol and ibuprofen; and attention deficit hyperactivity disorder (ADHD), comparing dexamphetamine or methylphenidate and placebo. Patients or their carers were surveyed before and after the trials by questionnaire, and after the trial by semi-structured interview with thematic analysis. Setting: Australian community-based patients and practitioners. Method: Forty-two patients with OA and 21 carers of patients with ADHD, for whom the effectiveness of proposed or existing medication was uncertain, completed the questionnaires, and 25 patients/carers (11 with OA and 14 with ADHD) participated in semi-structured interviews. Results: Patients in this purposive sample were generally very satisfied with the n-of-1 trial process. Their participation led to increased knowledge, awareness and understanding of their condition, their bodies' response to it, and its management. Some of this arose specifically from use of daily symptom diaries. This led to a sense of empowerment and control as well as improved individually-focused care. Conclusions: N-of-1 trials appeared to empower these patients as a result of both collecting information about their responses to different treatment options, and participating actively in subsequent therapeutic decisions. They are a patient-centred intervention that may improve medication management in suitable chronic diseases.

AB - Background: N-of-1 trials are within-patient, randomised, double-blind, placebo-controlled cross-over comparisons of two drugs for chronic illnesses. We have investigated the use of these, offered to doctors as individualised medication effectiveness tests (IMETs), as a tool to improve drug prescribing. Aim: To examine patient perspectives and experiences of n-of-1 trials. Design of study: We provided n-of-1 trials for osteoarthritis (OA), comparing paracetamol and ibuprofen; and attention deficit hyperactivity disorder (ADHD), comparing dexamphetamine or methylphenidate and placebo. Patients or their carers were surveyed before and after the trials by questionnaire, and after the trial by semi-structured interview with thematic analysis. Setting: Australian community-based patients and practitioners. Method: Forty-two patients with OA and 21 carers of patients with ADHD, for whom the effectiveness of proposed or existing medication was uncertain, completed the questionnaires, and 25 patients/carers (11 with OA and 14 with ADHD) participated in semi-structured interviews. Results: Patients in this purposive sample were generally very satisfied with the n-of-1 trial process. Their participation led to increased knowledge, awareness and understanding of their condition, their bodies' response to it, and its management. Some of this arose specifically from use of daily symptom diaries. This led to a sense of empowerment and control as well as improved individually-focused care. Conclusions: N-of-1 trials appeared to empower these patients as a result of both collecting information about their responses to different treatment options, and participating actively in subsequent therapeutic decisions. They are a patient-centred intervention that may improve medication management in suitable chronic diseases.

UR - http://www.scopus.com/inward/record.url?scp=14944353728&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 175

EP - 180

JO - Journal of the Royal College of General Practitioners

JF - Journal of the Royal College of General Practitioners

SN - 0960-1643

IS - 512

ER -